Table 3. The relationship between the expression of CUGBP1 and the clinical pathology.
| Score | P | |||||
|---|---|---|---|---|---|---|
| Colorectal cancer without liver metastasis | Metachronous liver metastasis | Synchronous live metastasis | Tumor tissue | Normal structure | ||
| Colorectal cancer without liver metastasis | 20 | 0.055 a | 0.001 a | |||
| Metachronous liver metastasis | 20 | 0.003 b | 0.003 b | |||
| Synchronous live metastasis | 20 | 0.636 c | 0.076 c | |||
| Sex | ||||||
| Male | 13 | 9 | 12 | 0.441 | 0.088 | |
| Female | 7 | 11 | 8 | |||
| Age | ||||||
| <62 | 12 | 11 | 12 | 0.143 | 0.532 | |
| ≥62 | 8 | 9 | 8 | |||
| Site | ||||||
| Colon | 15 | 10 | 12 | 0.605 | 0.212 | |
| Rectal | 5 | 10 | 8 | |||
| Size | ||||||
| <5 cm | 13 | 15 | 12 | 0.677 | 0.823 | |
| ≥5 cm | 4 | 5 | 8 | |||
| Pathological type | ||||||
| Fungating type | 8 | 6 | 7 | 0.875 | 0.878 | |
| Ulcer type | 12 | 14 | 13 | |||
| Histological type | ||||||
| Adenocarcinoma | 18 | 19 | 19 | 0.044 | 0.032 | |
| Mucinous adenocarcinoma | 2 | 1 | 1 | |||
| Differentiation | ||||||
| I–II | 10 | 10 | 9 | 0.165 | 0.351 | |
| III–IV | 10 | 10 | 11 | |||
| Infiltration depth | ||||||
| T1–T2 | 7 | 5 | 5 | 0.534 | 0.226 | |
| T3–T4 | 13 | 15 | 15 | |||
| Lymphatic metastasis | ||||||
| (–) | 13 | 13 | 15 | 0.764 | 0.261 | |
| (+) | 7 | 7 | 5 | |||
| Cancerous node | ||||||
| (–) | 14 | 11 | 12 | 0.221 | 0.547 | |
| (+) | 6 | 9 | 8 | |||
| Lymphatic or blood vessel invasion | ||||||
| No | 3 | 5 | 3 | 0.051 | 0.053 | |
| Yes | 17 | 15 | 17 | |||
| Perineural invasion | ||||||
| No | 12 | 14 | 11 | 0.421 | 0.572 | |
| Yes | 8 | 6 | 9 | |||
a, colorectal cancer without liver metastasis vs. metachronous liver metastasis; b, colorectal cancer without liver metastasis vs. synchronous live metastasis; c, metachronous liver metastasis vs. synchronous live metastasis.